Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
6 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

  • Read Robotics and GMP: Building the Factory of Tomorrow
    • Drug Production
    • Quality
    • Quality Assurance & cGMP
    • Contract Manufacturing (CDMO/CMO)
    • Continuous Manufacturing
    • Sterile Manufacturing
    • Pharmaceutical Compliance
    • Pharma Regulation
    • Pharma Policy
    • Tech and Innovation
    • AI and Automation
    • Labelling and Packaging

    Robotics and GMP: Building the Factory of Tomorrow

  • Read FDA Oncology Trial Guidance Targets Eligibility Barriers
    • Clinical Trial Regulation
    • Oncology
    • Clinical Trial Design
    • Pharma Policy
    • Pharma Regulation
    • Global Regulatory Affairs
    • Patient Enrolment
    • patient stratification
    • Oncology & Radiotherapeutics
    • Clinical Data
    • clinical trials
    • Clinical Trial Strategy

    FDA Oncology Trial Guidance Targets Eligibility Barriers

  • Read EHR Patient Recruitment Gets A Reality Check
    • Patient Enrolment
    • patient stratification
    • Clinical Trial Strategy
    • Electronic Data Capture
    • Clinical Trial Design
    • AI in Clinical Trials
    • Clinical Data
    • AI & Machine Learning

    EHR Patient Recruitment Gets A Reality Check

  • Read Could q-CAR Redefine Drug Discovery?
    • Drug Discovery
    • Biomedical R&D
    • AI Drug Discovery
    • Genetics & Molecular Biology
    • Research Informatics
    • Translational & Pre-clinical Research
    • Preclinical Development
    • Precision Medicine
    • AI & Machine Learning
    • Pharmaceutical R&D
    • pharma R&D
    • Computational Biology
    • Machine Learning in Pharma
    • HTS and Automation
    • Pharmacology
    • Small Molecules
    • The Discovery Loop
    • Tech and Innovation

    Could q-CAR Redefine Drug Discovery?